https://simplecast.com the limbic Independent news and perspective for medical specialists around Australia. For more news relevant to your speciality visit us at thelimbic.com Limbic Digital Media en Thu, 20 Apr 2023 02:18:40 +0000 Thu, 20 Apr 2023 02:18:51 +0000 www.thelimbic.com the limbic https://image.simplecastcdn.com/images/625cf068-4381-4a96-971a-7ccc5429c672/a6fc50b2-c6b7-4e53-b137-e6d01bf187f4/3000x3000/thelimbic-marknocircle-black.jpg?aid=rss_feed www.thelimbic.com episodic Independent news and perspective for medical specialists around Australia. For more news relevant to your speciality visit us at thelimbic.com thelimbic.com no https://feeds.simplecast.com/ii5zL65g thelimbic.com editor@thelimbic.com 142080f0-5cd2-4969-9154-b9eba3aa50bc Dr Anne Tonkin on what specialists need to know about CPD in 2023 Thu, 20 Apr 2023 02:18:40 +0000 editor@thelimbic.com (Medical Board of Australia, Dr Anne Tonkin) https://thelimbic.com Dr Anne Tonkin on what specialists need to know about CPD in 2023 Medical Board of Australia, Dr Anne Tonkin 00:19:31 This January saw the roll out of the Medical Board of Australia’s updated CPD requirements – all registered doctors are now required to complete 50 hours of CPD annually – this includes preparing a professional development plan, and at least 25 hours spent on activities related to reviewing performance and measuring outcomes. Now four months into the program, Chair of the Medical Board of Australia, Dr Anne Tonkin speaks to the limbic about the changes – why they were introduced, how the 50 hours are broken down, what the professional development plan looks like and her thoughts on how the changes will impact clinicians. This January saw the roll out of the Medical Board of Australia’s updated CPD requirements – all registered doctors are now required to complete 50 hours of CPD annually – this includes preparing a professional development plan, and at least 25 hours spent on activities related to reviewing performance and measuring outcomes. Now four months into the program, Chair of the Medical Board of Australia, Dr Anne Tonkin speaks to the limbic about the changes – why they were introduced, how the 50 hours are broken down, what the professional development plan looks like and her thoughts on how the changes will impact clinicians. cpd, dr anne tonkin, medical cpd, medical board of australia no full 23 1 bf7c577b-f239-447b-8b76-f16b8095f98d CAR-T in the UK: What’s next Mon, 6 Jun 2022 02:00:00 +0000 editor@thelimbic.com (thelimbic.com) www.thelimbic.com CAR-T in the UK: What’s next thelimbic.com 00:29:40 no full 22 1 c8e300cc-003d-4f73-81e7-a97e7bc1de23 CAR-T in the UK: A unique roll out Wed, 1 Jun 2022 22:30:22 +0000 editor@thelimbic.com (thelimbic.com) www.thelimbic.com CAR-T in the UK: A unique roll out thelimbic.com 00:34:28 In this first of two episodes, we speak to two leading UK haematologists, Dr Robin Sanderson (King’s College London) and Dr Caroline Besley (Bristol), about the innovative way in which CAR-T was introduced in the UK, the challenges that have been overcome, including the impact of Covid-19, and what they have learnt so far about using this highly personalised therapy. In this first of two episodes, we speak to two leading UK haematologists, Dr Robin Sanderson (King’s College London) and Dr Caroline Besley (Bristol), about the innovative way in which CAR-T was introduced in the UK, the challenges that have been overcome, including the impact of Covid-19, and what they have learnt so far about using this highly personalised therapy. no full 21 1 e77aca6c-c347-4afd-bc9d-9a2062d270ab PODCAST: GESA 21 conference wrap with Dr Thomas Tu and Dr Avik Majumdar Mon, 20 Sep 2021 21:00:00 +0000 editor@thelimbic.com (thelimbic.com) www.thelimbic.com PODCAST: GESA 21 conference wrap with Dr Thomas Tu and Dr Avik Majumdar thelimbic.com 00:32:02 In this podcast senior researcher at the Westmead Institute for Medical Research, Dr Thomas Tu discusses the latest developments in hepatitis B presented at this year’s GESA scientific meeting - from new treatments under development that bring the promise of cure closer to public health viral elimination strategies. And Dr Avik Majumdar, transplant hepatologist at the Royal Prince Alfred Hospital in Sydney shares his highlights from the Liver stream discussing new data identifying sub groups and prognosis in decompensated cirrhosis, new treatment developments in  primary sclerosing cholangitis and liver disease and the increasing role of non-invasive evaluation on prognosis in liver disease. In this podcast senior researcher at the Westmead Institute for Medical Research, Dr Thomas Tu discusses the latest developments in hepatitis B presented at this year’s GESA scientific meeting - from new treatments under development that bring the promise of cure closer to public health viral elimination strategies. And Dr Avik Majumdar, transplant hepatologist at the Royal Prince Alfred Hospital in Sydney shares his highlights from the Liver stream discussing new data identifying sub groups and prognosis in decompensated cirrhosis, new treatment developments in  primary sclerosing cholangitis and liver disease and the increasing role of non-invasive evaluation on prognosis in liver disease. no full 20 1 110850c2-f12c-4d94-a803-f3e9bcc19e7a Familial Hypercholesterolaemia: what you need to know about the MBS listed genetic test and the latest treatment updates Access the guidelines in summary and in full here:

Essentials of a new clinical practice guidance on familial hypercholesterolaemia for physicians

Integrated Guidance for Enhancing the Care of Familial Hypercholesterolaemia in Australia

 

 

 

]]> Thu, 2 Sep 2021 21:00:00 +0000 editor@thelimbic.com (thelimbic.com) www.thelimbic.com Access the guidelines in summary and in full here:

Essentials of a new clinical practice guidance on familial hypercholesterolaemia for physicians

Integrated Guidance for Enhancing the Care of Familial Hypercholesterolaemia in Australia

 

 

 

]]> Familial Hypercholesterolaemia: what you need to know about the MBS listed genetic test and the latest treatment updates thelimbic.com 00:30:14 New FH guidance signal the shift into the era of genetic medicine for cardiologists according to specialists who foresee increased numbers of individuals being identified with heritable gene mutations from the recent publicly funded genetic testing. The. updated Guidance released earlier this year covers updates in diagnosis and genetic testing , risk stratification, management and the latest evidence around new treatments. In this episode lipid specialist Associate Professor David Sullivan and genetics counsellor Catherine Spinks discuss the details of the genetic test and how it fits into diagnosis and screening protocols. And paediatric cardiologist Dr Ari Horton joins us to discuss how the introduction of the MBS funded genetic test will provide the very real opportunity to expand the number of potential cases detected. New FH guidance signal the shift into the era of genetic medicine for cardiologists according to specialists who foresee increased numbers of individuals being identified with heritable gene mutations from the recent publicly funded genetic testing. The. updated Guidance released earlier this year covers updates in diagnosis and genetic testing , risk stratification, management and the latest evidence around new treatments. In this episode lipid specialist Associate Professor David Sullivan and genetics counsellor Catherine Spinks discuss the details of the genetic test and how it fits into diagnosis and screening protocols. And paediatric cardiologist Dr Ari Horton joins us to discuss how the introduction of the MBS funded genetic test will provide the very real opportunity to expand the number of potential cases detected. no full 19 1 1bdbebdf-b30f-4522-9f7a-13a0fd800c6b CSANZ 21 conference highlights with A/Prof James Chong and Prof Liza Thomas Thu, 12 Aug 2021 21:00:00 +0000 editor@thelimbic.com (thelimbic.com) www.thelimbic.com CSANZ 21 conference highlights with A/Prof James Chong and Prof Liza Thomas thelimbic.com 00:21:31 In this podcast Associate Professor James Chong, scientific program chair, discusses the latest translational research discussed at this year’s scientific meeting – from new stem cell technologies that will reduce the need for heart transplantations to the clinical consequences of cardiac fibrosis and opportunities for treatment. Professor Liza Thomas, cardiac imaging stream lead, also shares her highlights discussing new data presented on myocardial function post COVID, the emerging field of cardio-oncology and the role of imaging in sub-clinical heart failure. In this podcast Associate Professor James Chong, scientific program chair, discusses the latest translational research discussed at this year’s scientific meeting – from new stem cell technologies that will reduce the need for heart transplantations to the clinical consequences of cardiac fibrosis and opportunities for treatment. Professor Liza Thomas, cardiac imaging stream lead, also shares her highlights discussing new data presented on myocardial function post COVID, the emerging field of cardio-oncology and the role of imaging in sub-clinical heart failure. no full 17 1 16e65507-9690-465f-9174-f48585b0217f MOGA 21 highlights: meet the YOGA research award winners Thu, 12 Aug 2021 21:00:00 +0000 editor@thelimbic.com (thelimbic.com) www.thelimbic.com MOGA 21 highlights: meet the YOGA research award winners thelimbic.com 00:15:57 In this MOGA 21 highlights episode Dr Christina Teng, winner of this year's YOGA oral abstract prize, discusses her work looking into just how long chemotherapy induced peripheral neuropathy (CIPN) persists that provides some fascinating insights that could help clinicians discuss the side effect with patients. We also speak to Dr Wei Hong, winner of this year's poster presentation, who discusses his latest work looking into a new approach to conducting oncology clinical trials that could save much needed time and money. In this MOGA 21 highlights episode Dr Christina Teng, winner of this year's YOGA oral abstract prize, discusses her work looking into just how long chemotherapy induced peripheral neuropathy (CIPN) persists that provides some fascinating insights that could help clinicians discuss the side effect with patients. We also speak to Dr Wei Hong, winner of this year's poster presentation, who discusses his latest work looking into a new approach to conducting oncology clinical trials that could save much needed time and money. no full 18 1 87432500-8ea4-4adb-b252-898ea4cb7b73 PODCAST: Tips to overcome diagnosing and treatment challenges in ANCA-associated vasculitis This series is a collaboration with the Australian Rheumatology Association and the limbic. New episodes of season one will drop every week over the next four weeks, so be sure to follow the limbic podcast in your favourite podcast app so you don’t miss out. You can also visit us at the limbic to get all the latest rheumatology news delivered to your email.

]]> Thu, 15 Jul 2021 23:41:43 +0000 editor@thelimbic.com (thelimbic.com) www.thelimbic.com This series is a collaboration with the Australian Rheumatology Association and the limbic. New episodes of season one will drop every week over the next four weeks, so be sure to follow the limbic podcast in your favourite podcast app so you don’t miss out. You can also visit us at the limbic to get all the latest rheumatology news delivered to your email.

]]> PODCAST: Tips to overcome diagnosing and treatment challenges in ANCA-associated vasculitis thelimbic.com 00:35:48 While ANCA-associated vasculitis can be described, in short, as damage to small blood vessels, there is a whole raft of different manifestations and symptoms to unravel to get to a diagnosis. The skin may be involved, as may the heart, kidneys, lungs, sinuses, the eyes, ears and nervous system - with management strategies dictated by the extent and severity to which organs are involved. In part two of our episode on vasculitis Dr Tony Sammel and Dr Daman Langguth share their experiences and tips diagnosing and treating ANCA-associated vasculitis. Dr Daman Langguth is VMO at Wesley Hospital, Brisbane, Director of Immunology and Chair of Partners Sullivan Nicolaides Pathology and Treasurer of the Australian and New Zealand Vasculitis Society. Dr Tony Sammel is staff specialist in rheumatology at Prince of Wales Hospital in Randwick and Sydney Eye Hospitals, where he coordinates the rheumatology vasculitis service, he has teaching appointments at the University of NSW and is Director of the Australian and New Zealand Vasculitis Society. While ANCA-associated vasculitis can be described, in short, as damage to small blood vessels, there is a whole raft of different manifestations and symptoms to unravel to get to a diagnosis. The skin may be involved, as may the heart, kidneys, lungs, sinuses, the eyes, ears and nervous system - with management strategies dictated by the extent and severity to which organs are involved. In part two of our episode on vasculitis Dr Tony Sammel and Dr Daman Langguth share their experiences and tips diagnosing and treating ANCA-associated vasculitis. Dr Daman Langguth is VMO at Wesley Hospital, Brisbane, Director of Immunology and Chair of Partners Sullivan Nicolaides Pathology and Treasurer of the Australian and New Zealand Vasculitis Society. Dr Tony Sammel is staff specialist in rheumatology at Prince of Wales Hospital in Randwick and Sydney Eye Hospitals, where he coordinates the rheumatology vasculitis service, he has teaching appointments at the University of NSW and is Director of the Australian and New Zealand Vasculitis Society. no full 15 1 6ecef92d-5ebe-40dd-9f11-b7fc72b2cc4c PODCAST: Vasculitis: tips to overcome challenges in diagnosing and treating Giant Cell Arteritis Thu, 8 Jul 2021 14:00:00 +0000 editor@thelimbic.com (thelimbic.com) www.thelimbic.com PODCAST: Vasculitis: tips to overcome challenges in diagnosing and treating Giant Cell Arteritis thelimbic.com 00:37:24 Clinicians who treat vasculitis are familiar with uncertainty.  In its many forms, and with no single sign, symptom or investigation strong enough to confirm a diagnosis, vasculitis presents an extensive list of challenges in a setting where diagnostic delay can lead to devastating consequences. In episode three of our Rheumatology Advanced Trainee series we deep dive into two types of vasculitis -  giant cell arteritis (GCA) here in part 1 and ANCA-associated vasculitis next week in part 2. You'll hear Dr Tony Sammel and Dr Daman Langguth discuss what they’ve learned about how to diagnose the rare condition and how to best support patients through treatment decisions and relapse. They’ll share tips on how to overcome some of the challenges associated with ruling out other more common conditions, making decisions around imaging and biopsy as well as discussing some of the latests evidence around treatments. With many practical tips and insights this episode is a great listen. Dr Daman Langguth is VMO at Wesley Hospital, Brisbane, director of Immunology and chair of Partners Sullivan Nicolaides Pathology and treasurer of the Australian and New Zealand Vasculitis Society. Dr Tony Sammel is staff specialist in rheumatology at Prince of Wales Hospital in Randwick and Sydney Eye Hospitals, where he coordinates the rheumatology vasculitis service, he has teaching appointments at the University of NSW and is Director of the Australian and New Zealand Vasculitis Society. This series is a collaboration with the Australian Rheumatology Association and the limbic. New episodes of season one will be drop every week over the next four weeks, so be sure to follow the limbic podcast in your favourite podcast app so you don’t miss out. You can also visit us at the limbic to get all the latest rheumatology news delivered to your email. Clinicians who treat vasculitis are familiar with uncertainty.  In its many forms, and with no single sign, symptom or investigation strong enough to confirm a diagnosis, vasculitis presents an extensive list of challenges in a setting where diagnostic delay can lead to devastating consequences. In episode three of our Rheumatology Advanced Trainee series we deep dive into two types of vasculitis -  giant cell arteritis (GCA) here in part 1 and ANCA-associated vasculitis next week in part 2. You'll hear Dr Tony Sammel and Dr Daman Langguth discuss what they’ve learned about how to diagnose the rare condition and how to best support patients through treatment decisions and relapse. They’ll share tips on how to overcome some of the challenges associated with ruling out other more common conditions, making decisions around imaging and biopsy as well as discussing some of the latests evidence around treatments. With many practical tips and insights this episode is a great listen. Dr Daman Langguth is VMO at Wesley Hospital, Brisbane, director of Immunology and chair of Partners Sullivan Nicolaides Pathology and treasurer of the Australian and New Zealand Vasculitis Society. Dr Tony Sammel is staff specialist in rheumatology at Prince of Wales Hospital in Randwick and Sydney Eye Hospitals, where he coordinates the rheumatology vasculitis service, he has teaching appointments at the University of NSW and is Director of the Australian and New Zealand Vasculitis Society. This series is a collaboration with the Australian Rheumatology Association and the limbic. New episodes of season one will be drop every week over the next four weeks, so be sure to follow the limbic podcast in your favourite podcast app so you don’t miss out. You can also visit us at the limbic to get all the latest rheumatology news delivered to your email. no full 14 1 ca644fa5-b08b-4d24-b51b-b6745ca800f7 PODCAST: Flipping the fibromyalgia paradigm: how changing the way you think about chronic pain benefits patients Thu, 1 Jul 2021 21:00:00 +0000 editor@thelimbic.com (thelimbic.com) www.thelimbic.com PODCAST: Flipping the fibromyalgia paradigm: how changing the way you think about chronic pain benefits patients thelimbic.com 00:40:11 On episode 2 of our podcast series for rheumatology advanced trainees we share a fascinating conversation on fibromyalgia with the inspiring Dr Sam Whittle, Dr Emma Guymer and Dr Richard Kwiatek. This series is a collaboration with the Australian Rheumatology Association and the limbic. New episodes of season one will  drop every week over the next four weeks, so be sure to follow the limbic podcast in your favourite podcast app so you don’t miss out. You can also visit us at the limbic to get all the latest rheumatology news delivered to your email. In this conversation you'll hear about how each practitioner has come to accept and work with the ambiguity that comes with a  fibromyalgia diagnosis.  They’ll share tips on how to talk to patients with about their diagnosis, the ins and outs of working in the public and private setting, overcoming treatment challenges, as well as discussing the rewards that come with being able to walk alongside patients through a journey to self management. Dr Emma Guymer has been engaged in clinical care and research with fibromyalgia patients for over 20 years. She currently heads the Monash Fibromyalgia Clinic at Monash Medical Centre in Melbourne. Dr Richard Kwiatek works primarily in private rheumatology practice and has a long-standing clinical and research interest in medically unexplained pain and fatigue syndromes. Dr Sam Whittle is a senior consultant rheumatologist at the Queen Elizabeth Hospital in Adelaide and a senior lecturer at the University of Adelaide He is a Board member of the Australian Rheumatology Association and sits on the Steering Committee of the South Australian Statewide Chronic Pain Clinical Network. On episode 2 of our podcast series for rheumatology advanced trainees we share a fascinating conversation on fibromyalgia with the inspiring Dr Sam Whittle, Dr Emma Guymer and Dr Richard Kwiatek. This series is a collaboration with the Australian Rheumatology Association and the limbic. New episodes of season one will  drop every week over the next four weeks, so be sure to follow the limbic podcast in your favourite podcast app so you don’t miss out. You can also visit us at the limbic to get all the latest rheumatology news delivered to your email. In this conversation you'll hear about how each practitioner has come to accept and work with the ambiguity that comes with a  fibromyalgia diagnosis.  They’ll share tips on how to talk to patients with about their diagnosis, the ins and outs of working in the public and private setting, overcoming treatment challenges, as well as discussing the rewards that come with being able to walk alongside patients through a journey to self management. Dr Emma Guymer has been engaged in clinical care and research with fibromyalgia patients for over 20 years. She currently heads the Monash Fibromyalgia Clinic at Monash Medical Centre in Melbourne. Dr Richard Kwiatek works primarily in private rheumatology practice and has a long-standing clinical and research interest in medically unexplained pain and fatigue syndromes. Dr Sam Whittle is a senior consultant rheumatologist at the Queen Elizabeth Hospital in Adelaide and a senior lecturer at the University of Adelaide He is a Board member of the Australian Rheumatology Association and sits on the Steering Committee of the South Australian Statewide Chronic Pain Clinical Network. no full 13 1 5b956012-a084-4efd-839c-bd006ccad693 Highlights from the ARA 2021 Conference Thu, 27 May 2021 14:00:00 +0000 editor@thelimbic.com (thelimbic.com) www.thelimbic.com Highlights from the ARA 2021 Conference thelimbic.com 00:18:11 In this episode the limbic talks to Associate Professor Peter Wong, convenor of this years' scientific meeting, about the highlights from the hybrid event. In this episode the limbic talks to Associate Professor Peter Wong, convenor of this years' scientific meeting, about the highlights from the hybrid event. no full 11 1 d8876662-c884-4791-a346-5fa76b4e7635 Podcast: Prof Paul Zimmet and the other pandemic: lessons from the war against diabetes Tue, 18 May 2021 14:00:00 +0000 editor@thelimbic.com (thelimbic.com) www.thelimbic.com Podcast: Prof Paul Zimmet and the other pandemic: lessons from the war against diabetes thelimbic.com 00:32:05 Professor Paul Zimmet believes that serendipity and chance have played a central role in his career. From reading an article on diabetes in a discarded Lancet during a cold London Christmas to finding himself sitting on a beach next to a director of the World Health Organisation, he’s embraced opportunities that arose from being in the right place at the right time. Lucky breaks aside, Professor Zimmet’s hard work and determination have undoubtedly led to his string of achievements in the world of diabetes and obesity. He founded the International Diabetes Institute and his epidemiological studies have predicted and charted the global type 2 diabetes epidemic. He was integral to the establishment of the National Diabetes Strategy and continues to advise governments on ways to manage diabetes and obesity. In this episode, we talk to Professor Zimmet about his career highlights, how he works to inspire policy makers to get behind a cause, and his two current passions: establishing a registry for more insight into the link between COVID and diabetes, and researching technology that has the potential to revolutionise the way we handle insulin. LISTEN NOW Professor Paul Zimmet believes that serendipity and chance have played a central role in his career. From reading an article on diabetes in a discarded Lancet during a cold London Christmas to finding himself sitting on a beach next to a director of the World Health Organisation, he’s embraced opportunities that arose from being in the right place at the right time. Lucky breaks aside, Professor Zimmet’s hard work and determination have undoubtedly led to his string of achievements in the world of diabetes and obesity. He founded the International Diabetes Institute and his epidemiological studies have predicted and charted the global type 2 diabetes epidemic. He was integral to the establishment of the National Diabetes Strategy and continues to advise governments on ways to manage diabetes and obesity. In this episode, we talk to Professor Zimmet about his career highlights, how he works to inspire policy makers to get behind a cause, and his two current passions: establishing a registry for more insight into the link between COVID and diabetes, and researching technology that has the potential to revolutionise the way we handle insulin. LISTEN NOW no full 10 1 c20bc59b-8aed-43e1-9f84-37d6f1b8ef3d HIGHLIGHTS FROM THE TSANZSRS 2021 CONFERENCE Thu, 6 May 2021 14:00:00 +0000 editor@thelimbic.com (thelimbic.com) www.thelimbic.com HIGHLIGHTS FROM THE TSANZSRS 2021 CONFERENCE thelimbic.com 00:28:10 Tackling some of the biggest global challenges from respiratory health in the face of climate change to fighting big tobacco and COVID-19 as well as highlighting important developments in respiratory genetics and technology - this year's TSANZSRS conference covered a lot of ground. In this podcast the limbic talks to Professor Gary Anderson, Associate Professor Lucy Burr and Danny Brazzale about their highlights from the 2021 meeting. Tackling some of the biggest global challenges from respiratory health in the face of climate change to fighting big tobacco and COVID-19 as well as highlighting important developments in respiratory genetics and technology - this year's TSANZSRS conference covered a lot of ground. In this podcast the limbic talks to Professor Gary Anderson, Associate Professor Lucy Burr and Danny Brazzale about their highlights from the 2021 meeting. no full 9 1 0ea171d1-498e-4efd-a8f7-8ad66c5aa18e Frontline stories: the toll of COVID-19 and the mental health of doctors in Australia Mon, 19 Apr 2021 14:00:00 +0000 editor@thelimbic.com (Associate Professor Natasha Smallwood, Professor Karen Willis) www.thelimbic.com Frontline stories: the toll of COVID-19 and the mental health of doctors in Australia Associate Professor Natasha Smallwood, Professor Karen Willis 00:39:40 The largest survey of Australia’s healthcare workers has highlighted the sharp rise in mental health symptoms experienced by doctors and health care workers around the country throughout the COVID-19 pandemic. The Australian Frontline Healthcare Workers Study was distributed nationally in September last year at the height of Victoria’s COVID-19 second wave amid nearly four months of strict lockdown, receiving record responses. Over eight weeks close to 10,0000 healthcare workers participated in the survey speaking of burnout, feeling unsafe at work, and frustration with misplaced funding and inadequate quick fixes. Detailed stories from senior clinicians, junior doctors, allied health workers and hospital administrators have revealed the magnitude of mental health symptoms experienced throughout the crisis: More than half of survey respondents had depression, while 70% of participants experienced emotional exhaustion and 41% experienced post traumatic stress disorder as measured on validated psychological scales. In this podcast lead investigators respiratory physician Associate Professor Natasha Smallwood and health sociologist Professor Karen Willis talk to the limbic about the key findings from their analysis and what Australia's healthcare workers say about how inevitable future crises should be handled to protect the mental health of frontline workers. The largest survey of Australia’s healthcare workers has highlighted the sharp rise in mental health symptoms experienced by doctors and health care workers around the country throughout the COVID-19 pandemic. The Australian Frontline Healthcare Workers Study was distributed nationally in September last year at the height of Victoria’s COVID-19 second wave amid nearly four months of strict lockdown, receiving record responses. Over eight weeks close to 10,0000 healthcare workers participated in the survey speaking of burnout, feeling unsafe at work, and frustration with misplaced funding and inadequate quick fixes. Detailed stories from senior clinicians, junior doctors, allied health workers and hospital administrators have revealed the magnitude of mental health symptoms experienced throughout the crisis: More than half of survey respondents had depression, while 70% of participants experienced emotional exhaustion and 41% experienced post traumatic stress disorder as measured on validated psychological scales. In this podcast lead investigators respiratory physician Associate Professor Natasha Smallwood and health sociologist Professor Karen Willis talk to the limbic about the key findings from their analysis and what Australia's healthcare workers say about how inevitable future crises should be handled to protect the mental health of frontline workers. covid 19, mental health, australian frontline healthcare workers study no full 8 1 afae7634-6173-4431-9a7e-88c7e4dd539a A treatment for silicosis? Prof Dan Chambers on the procedure that could halt the deadly disease https://onlinelibrary.wiley.com/doi/10.1111/resp.14018

]]> Thu, 4 Mar 2021 02:19:16 +0000 editor@thelimbic.com (Dan Chambers) www.thelimbic.com https://onlinelibrary.wiley.com/doi/10.1111/resp.14018

]]> A treatment for silicosis? Prof Dan Chambers on the procedure that could halt the deadly disease Dan Chambers 00:21:43 Professor Dan Chambers was alarmed when he began seeing new cases of silicosis in dozens of young men in Queensland in 2018. The cases triggered a nationwide audit of the manufacturing stone industry, revealing that hundreds of workers have contracted the potentially fatal disease as a result of workplace safety breaches. The occupational lung condition is now said to be at epidemic levels in Australia. Knowing that many more young men would need help, Professor Chambers, Thoracic Transplant Physician at Prince Charles Hospital, Brisbane, and his colleagues began investigating an established technique – lung lavage – as a potential treatment. In this episode we talk to Professor Chambers about the procedure that has already been used to effectively treat six men with early stage silicosis and the plans to roll the program out across other states. Professor Dan Chambers was alarmed when he began seeing new cases of silicosis in dozens of young men in Queensland in 2018. The cases triggered a nationwide audit of the manufacturing stone industry, revealing that hundreds of workers have contracted the potentially fatal disease as a result of workplace safety breaches. The occupational lung condition is now said to be at epidemic levels in Australia. Knowing that many more young men would need help, Professor Chambers, Thoracic Transplant Physician at Prince Charles Hospital, Brisbane, and his colleagues began investigating an established technique – lung lavage – as a potential treatment. In this episode we talk to Professor Chambers about the procedure that has already been used to effectively treat six men with early stage silicosis and the plans to roll the program out across other states. silicosis, lung disease, lung lavage no full 7 1 3aa82b7f-2e5a-4ec9-992d-989ae72215e2 PODCAST: 'The Lost Tribe': The state of medical training in Australia You can view the full survey results here:  https://www.medicaltrainingsurvey.gov.au/.

]]> Mon, 1 Mar 2021 22:56:10 +0000 editor@thelimbic.com (Dr Hash Abdeen) www.thelimbic.com You can view the full survey results here:  https://www.medicaltrainingsurvey.gov.au/.

]]> PODCAST: 'The Lost Tribe': The state of medical training in Australia Dr Hash Abdeen 00:28:06 In this podcast Dr Hash Abdeen, Chair of the AMAs Council of Doctors in Training talks to the limbic about how the medical profession's hierarchal structure continues to breed a culture of systemic bullying, and how the COVID-19 pandemic has pushed the profession to look at new approaches to training and assessing junior doctors that could finally address the bottleneck leaving many trainees unable to move out of pre-vocational and unaccredited training. In this podcast Dr Hash Abdeen, Chair of the AMAs Council of Doctors in Training talks to the limbic about how the medical profession's hierarchal structure continues to breed a culture of systemic bullying, and how the COVID-19 pandemic has pushed the profession to look at new approaches to training and assessing junior doctors that could finally address the bottleneck leaving many trainees unable to move out of pre-vocational and unaccredited training. covid, doctors in training, bullying, ama, trainee no full 6 1 42999734-2ae4-4b41-bbb8-ac4d2a5f79d2 Dr Ranjana Srivastava on dying well and empathy in medicine Thu, 11 Feb 2021 13:00:00 +0000 editor@thelimbic.com (thelimbic.com) www.thelimbic.com Dr Ranjana Srivastava on dying well and empathy in medicine thelimbic.com 00:33:45 Oncologist, acclaimed author and journalist Dr Ranjana Srivastava talks to the limbic about the responsibility of practicing the art of empathy in medicine, negotiating difficult conversations and what she's learned from her patients over two decades about dying well. Ranjana Srivastava is an oncologist, award-winning author and columnist for The Guardian. She was awarded the Medal of the Order of Australia for her work on doctor-patient communication. Her book, Dying for a Chat: the communication breakdown between doctors and patients, won the 2013 human rights literature award. Oncologist, acclaimed author and journalist Dr Ranjana Srivastava talks to the limbic about the responsibility of practicing the art of empathy in medicine, negotiating difficult conversations and what she's learned from her patients over two decades about dying well. Ranjana Srivastava is an oncologist, award-winning author and columnist for The Guardian. She was awarded the Medal of the Order of Australia for her work on doctor-patient communication. Her book, Dying for a Chat: the communication breakdown between doctors and patients, won the 2013 human rights literature award. no full 5 1 7a03bf26-d2a5-4df1-98ce-6bbe5fddbd2e Transitioning From Paediatric To Adult Care In Rheumatology https://bmjopen.bmj.com/content/11/1/e039670.long

]]> Thu, 4 Feb 2021 21:09:41 +0000 editor@thelimbic.com (Gabor Major David Tunnicliffe, Fiona Niddrie) www.thelimbic.com https://bmjopen.bmj.com/content/11/1/e039670.long

]]> Transitioning From Paediatric To Adult Care In Rheumatology Gabor Major David Tunnicliffe, Fiona Niddrie 00:20:39 In this podcast we talk to rheumatologist Dr Gabor Major, rheumatology clinical nurse consultant Fiona Nidddrie and research fellow Dr David Tunnicliffe from the Adolescent and Young Adult with Rheumatic Disease (AYARD) clinic at John Hunter Hospital in Newcastle about the role clinicians play in helping young rheumatology patients transition to adult healthcare. They share fascinating insights from their study that investigates how young rheumatology patients and their parents experience transition care. With up to half of adolescent patients who move to adult care lost to follow-up within 2 years, their findings shed a light on what can change to improve adolescent outcomes into adulthood. In this podcast we talk to rheumatologist Dr Gabor Major, rheumatology clinical nurse consultant Fiona Nidddrie and research fellow Dr David Tunnicliffe from the Adolescent and Young Adult with Rheumatic Disease (AYARD) clinic at John Hunter Hospital in Newcastle about the role clinicians play in helping young rheumatology patients transition to adult healthcare. They share fascinating insights from their study that investigates how young rheumatology patients and their parents experience transition care. With up to half of adolescent patients who move to adult care lost to follow-up within 2 years, their findings shed a light on what can change to improve adolescent outcomes into adulthood. rheumatology, transission care yes full 4 1 06fdc8d9-54e8-49cc-ac34-87b95f2e5dd9 What to expect in cardiology in 2021: An interview with Prof Clara Chow From the new

]]> Tue, 2 Feb 2021 13:00:00 +0000 editor@thelimbic.com (thelimbic.com) www.thelimbic.com From the new

]]> What to expect in cardiology in 2021: An interview with Prof Clara Chow thelimbic.com 00:23:07 In this podcast we speak to CSANZ President Professor Clara Chow about her thoughts on where SGLT2 inhibitors will fit into clinical practice, how the ongoing affects of COVID-19 will impact the delivery of cardiac services as well as her thoughts on what 2021 will bring to the field of cardiology in Australia. In this podcast we speak to CSANZ President Professor Clara Chow about her thoughts on where SGLT2 inhibitors will fit into clinical practice, how the ongoing affects of COVID-19 will impact the delivery of cardiac services as well as her thoughts on what 2021 will bring to the field of cardiology in Australia. sgl2 inhibitors, cvd, cardiovascular disease no full 3 1 e1d95816-cfd9-4096-8154-4824aea601bd PODCAST: Prof Bruce Thompson on what to expect in respiratory medicine in 2021 Wed, 27 Jan 2021 14:03:28 +0000 editor@thelimbic.com (Bruce Thompson) www.thelimbic.com PODCAST: Prof Bruce Thompson on what to expect in respiratory medicine in 2021 Bruce Thompson 00:34:52 A year into the coronavirus pandemic and now with a vaccine finally approved by the TGA for use in Australia we speak with TSANZ president Professor Bruce Thompson about vaccine rollout and how COVID-19 will continue to affect the field of respiratory medicine. We also talk about TSANZs controversial position on e-cigarettes, the devastating lung condition silicosis and how changing the language we use to talk about respiratory conditions could help make the biggest difference to patient outcomes in 2021. A year into the coronavirus pandemic and now with a vaccine finally approved by the TGA for use in Australia we speak with TSANZ president Professor Bruce Thompson about vaccine rollout and how COVID-19 will continue to affect the field of respiratory medicine. We also talk about TSANZs controversial position on e-cigarettes, the devastating lung condition silicosis and how changing the language we use to talk about respiratory conditions could help make the biggest difference to patient outcomes in 2021. covid-19 vaccine asthma copd respiratory medicine no full 2 1 c5aa8eab-f5de-425c-be37-6a4d4722005e PODCAST: What to expect in haematology 2021: An interview with Dr Leanne Berkahn Mon, 18 Jan 2021 00:04:51 +0000 editor@thelimbic.com (Dr Leanne Berkahn) www.thelimbic.com PODCAST: What to expect in haematology 2021: An interview with Dr Leanne Berkahn Dr Leanne Berkahn 00:24:05 From off-the-shelf CAR T-cell therapy products, and a big focus on drug-antibody conjugates and novel molecular compound trials to the search for new immunotherapy regimens we talk to HSANZ president Dr Leanne Berkahn about what 2021 will bring to the field of haematology. From off-the-shelf CAR T-cell therapy products, and a big focus on drug-antibody conjugates and novel molecular compound trials to the search for new immunotherapy regimens we talk to HSANZ president Dr Leanne Berkahn about what 2021 will bring to the field of haematology. immunotherapy, haematology, cellular therapy, car t, hsanz no full 1 1